Skip to main content

External Beam Radiotherapy for Bone Metastases

CBE ID
1822
1.4 Project
Endorsed
Endorsement Status
1.1 New or Maintenance
E&M Cycle
Is Under Review
No
1.3 Measure Description

This measure reports the percentage of patients, regardless of age, with a diagnosis of painful bone metastases and no history of previous radiation who receive external beam radiation therapy (EBRT) with an acceptable fractionation scheme as defined by the guideline.

        • 1.14 Numerator

          All patients, regardless of age, with painful bone metastases, and no previous radiation to the same anatomic site who receive EBRT with any of the following recommended fractionation schemes: 30Gy/10fxns, 24Gy/6fxns, 20Gy/5fxns, 8Gy/1fxn.

        • 1.15 Denominator

          All patients with painful bone metastases and no previous radiation to the same anatomic site who receive EBRT

        • Exclusions

          The medical reasons for denominator exclusions are:
          1) Previous radiation treatment to the same anatomic site;
          2) Patients with femoral axis cortical involvement greater than 3 cm in length;
          3) Patients who have undergone a surgical stabilization procedure; and
          4) Patients with spinal cord compression, cauda equina compression or radicular pain

        • Most Recent Endorsement Activity
          Measure Retired and Endorsement Removed Cancer Fall Cycle 2017
          Initial Endorsement
          Last Updated
          Removal Date